PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Natural ‘biopesticide’ against malaria mosquitoes successful in early field tests

Powder made from dead bacterial cells also kills mosquitoes resistant to chemical pesticides

2024-12-04
(Press-News.org)

An experimental bacteria-derived biopesticide is highly effective in killing malaria-carrying mosquitoes, including those that have developed resistance to chemical pesticides, according to initial field tests led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The biopesticide is a powder made from the dead cells of a common soil-dwelling bacterial species. The researchers showed that the biopesticide efficiently kills both ordinary and chemical-pesticide-resistant mosquitoes when included in standard baits. Even at sub-lethal doses, the biopesticide inhibits malaria transmission and makes mosquitoes more vulnerable to standard chemical pesticides. The encouraging findings from initial trials in western Africa suggest larger field tests could, if successful, one day lead to broad use of the new biopesticide in malaria-endemic parts of the world.

The study was published online December 4 in Science Advances.

“This biopesticide has a unique set of features that suggest it could be a powerful new weapon against malaria,” says study senior author George Dimopoulos, PhD, deputy director of the Johns Hopkins Malaria Research Institute in the Bloomberg School’s Department of Molecular Microbiology and Immunology.

Malaria, a parasitic disease spread by Anopheles mosquitoes, has long been one of the world’s top killers. According to World Health Organization estimates, there are about 250 million cases and 600,000 deaths annually, mostly children under five in sub-Saharan Africa. Malaria vaccines have been developed, but are not broadly available or very efficient in preventing disease. While mosquito-killing chemical pesticides have been the most effective weapons against malaria to date, the insects have developed significant resistance to these compounds. New antimalarial tools are urgently needed.

The new biopesticide emerged from a project conducted by Dimopoulos and his team in Panama more than a decade ago. The team caught wild mosquitoes and catalogued bacterial species in their gastrointestinal tracts to see if any could affect the mosquito’s ability to harbor and transmit pathogens. Ultimately, they found one, a species of Chromobacterium, that at low doses inhibits the insects’ ability to transmit pathogens such as the malaria parasite and dengue virus—and at higher doses kills both adult and larval mosquitoes. This discovery suggested the bacterium could be the first biopesticide for use against disease-transmitting mosquitoes.

To avoid the complications of working with a live organism, the researchers developed a powder preparation made from dead, dried cells of the bacterium. They found that the powder retains the bacterium’s mosquitocidal properties, and also has a years-long shelf life and very high heat stability. Early tests also found that the biopesticide has no evident toxic effects on mammalian cells, is readily ingested by mosquitoes when dissolved in standard mosquito baits, and—unlike chemical insecticides—does not lead to the development of genetic resistance in mosquitoes even after ten generations of mild exposure.

In the new study, the researchers tested the new biopesticide in laboratory conditions, and in “MosquitoSphere” facilities—large, net-enclosed spaces simulating village and agricultural settings—in Burkina Faso. The biopesticide killed both laboratory and wild-caught strains of Anopheles, including those with resistance to different kinds of chemical pesticides. Even when the biopesticide didn’t kill the insects, it largely reversed their chemical insecticide resistance.

At the highest dose of 200 mg/ml, the biopesticide wiped out the vast majority of the mosquitoes in the MosquitoSphere facilities, and the researchers’ mathematical modeling suggested that it would dramatically reduce local mosquito populations in real-world conditions.

Mosquitoes exposed to the biopesticide even at low doses were also severely impaired in their ability to seek out a host for blood meals. In the relatively few insects that succeeded in ingesting malaria parasite-infected blood in experiments, the ability of the parasites to infect the mosquito was sharply reduced as well. These results suggest that the biopesticide overall could have a very potent effect at reducing malaria transmission.

The researchers’ results so far suggest that the biopesticide works by modifying the activity of a key detoxification enzyme in mosquitoes, essentially turning the insects’ detox systems against them—which would explain why the biopesticide has such a strong synergy with chemical pesticides.

The researchers now plan to seek U.S. Environmental Protection Agency approval for the new biopesticide, and to set up larger-scale field tests to further assess its ability to reduce malaria incidence.

They also plan more experiments to identify the component or components of the Chromobacterium that account for its potent anti-mosquito effects.

“It was never my intention to focus on biopesticides,” says Dimopoulos, whose primary focus has been malaria mosquito immunity. “But that’s how these discoveries have worked out, and it’s exciting that we’ve identified something novel with malaria control potential.”

“Chromobacterium biopesticide overcomes insecticide resistance in malaria vector mosquitoes” was co-authored by Chinmay Tikhe, Sare Issiaka, Yuemei Dong, Mary Kefi, Mihra Tavadia, Etienne Bilgo, Rodrigo Corder, John Marshall, Abdoulaye Diabate, and George Dimopoulos.

Funding was provided by the U.S. Agency for International Development (USAID), the Innovative Vector Control Consortium, and the Johns Hopkins Malaria Research Institute.

# # #

END



ELSE PRESS RELEASES FROM THIS DATE:

NSF-Piedmont Triad Regenerative Medicine Engine (PTRME) awards $2.5 million in grants to drive economic growth

2024-12-04
WINSTON-SALEM, N.C. – December 4, 2024 — The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has announced a groundbreaking investment of $2.5 million in the region’s regenerative medicine industry through its inaugural Ecosystem Building Grant program. This milestone underscores PTRME’s leadership in regenerative medicine and commitment to positioning the Piedmont Triad as a global hub for innovation. Six innovative companies have been awarded grants ...

How plant enzymes can adapt to higher temperatures

2024-12-04
  Images EAST LANSING, Mich. – As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.  As global temperatures rise, it’s imperative that plants can adapt to new and changing conditions.  Michigan State University researchers from the Walker lab are looking at ways to give plants an assist. More specifically, their research aims to help plants adapt to changing temperatures by introducing engineered enzymes that will increase plants’ heat tolerance. “I would say that the main goal of our research is to prepare plants for elevated temperatures because, with climate change, ...

The Gerontological Society of America congratulates new 2024 Awardees

2024-12-04
The Gerontological Society of America (GSA) — the country’s largest interdisciplinary organization devoted to the field of aging — is proud to acknowledge the work of 34 outstanding individuals through its prestigious awards program. GSA salutes outstanding research, recognizes distinguished leadership in teaching and service, and fosters new ideas through a host of awards. Nominated by their peers, the recipients’ achievements serve as milestones in the history and development of gerontology. The awardees were honored at various ...

New facility for evaluating hydrogen-compatible materials now complete

New facility for evaluating hydrogen-compatible materials now complete
2024-12-04
1. NIMS has established and begun operating a new testing facility to evaluate the mechanical properties of materials exposed to low-temperature hydrogen environments. This facility can create hydrogen conditions across a broader range of temperatures and pressures than any other facility of its kind in the world. It is designed to assess the properties of materials when in contact with low-temperature gaseous or liquefied hydrogen, with the goal of developing cost-effective materials for hydrogen supply chains. This approach is expected to reduce the cost of producing and operating ...

Manta rays inspire the fastest swimming soft robot yet

Manta rays inspire the fastest swimming soft robot yet
2024-12-04
A team of researchers has beaten its own record for the fastest swimming soft robot, drawing inspiration from manta rays to improve their ability to control the robot’s movement in the water. “Two years ago, we demonstrated an aquatic soft robot that was able to reach average speeds of 3.74 body lengths per second,” says Jie Yin, corresponding author of a paper on the work and an associate professor of mechanical and aerospace engineering at North Carolina State University. “We have improved on that design. Our new soft robot is more energy efficient and reaches a speed of 6.8 body lengths per second. In addition, the previous model could only swim on the surface ...

With a quarter-century of data on gun usage, new study examines when and why people start carrying guns and if they persist in doing so

2024-12-04
A new long-term study that has documented the lives of a diverse sample of children over the past three decades shows that the majority of gun carriers began to carry in adulthood, not adolescence. These two groups — which the authors call “adult-onset carriers” if they began carrying after 21 years of age and “adolescent-onset carriers” if their carrying started prior to 21 years of age — have very different patterns in exposure to violence prior to carrying, persistence in carrying, and in actual gun usage. In “Dual Pathways of ...

How did humans and dogs become friends? Connections in the Americas began 12,000 years ago

How did humans and dogs become friends? Connections in the Americas began 12,000 years ago
2024-12-04
"Dog is man's best friend" may be an ancient cliché, but when that friendship began is a longstanding question among scientists. A new study led by a University of Arizona researcher is one step closer to an answer on how Indigenous people in the Americas interacted with early dogs and wolves. The study, published today in the journal Science Advances and based on archaeological remains from Alaska, shows that people and the ancestors of today's dogs began forming close relationships as early as 12,000 years ago – ...

A third of people from Chicago carry concealed handguns in public before they reach middle age, major 25-year study finds

2024-12-04
Around a third (32%) of people who grew up in Chicago have carried a concealed firearm on the city streets at least once by the time they turn 40 years old, according to a major study of gun usage taking in a quarter of a century of data. Urban sociologists behind the research argue that such carry rates are likely to be similar across many other major US cities.  The research suggests that almost half of men (48%) have carried a concealed gun by the age of 40, compared to just 16% of women.* The study, published in Science Advances, is one of the few to track gun usage in the same US population ...

Why some individuals believe fake news and conspiracies

Why some individuals believe fake news and conspiracies
2024-12-04
People who are credulous are less capable of recognizing fake news, and along with mistrustful adults, are more susceptible to conspiracy thinking and vaccine hesitancy, according to a study published December 4, 2024, in the open-access journal PLOS Global Public Health by Michal Tanzer and colleagues from University College London, U.K. Epistemic trust is the readiness to regard knowledge communicated by others as significant, self-relevant, and generalizable to other contexts. Disruption to the capacity for epistemic trust may undermine healthy functioning that requires rapid, efficient checking and updating of social knowledge ...

Misokinesia, intolerance of others' fidgeting and repetitive body movements, can cause people to experience intense reactions, negative emotions and relationship strain, per qualitative study

Misokinesia, intolerance of others fidgeting and repetitive body movements, can cause people to experience intense reactions, negative emotions and relationship strain, per qualitative study
2024-12-04
Misokinesia, intolerance of others' fidgeting and repetitive body movements, can cause people to experience intense reactions, negative emotions and relationship strain, per qualitative study ### Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0313169 Article Title: I struggle with your fidgeting: A qualitative study of the personal and social impacts of misokinesia Author Countries: Canada, U.S. Funding: We received funding from Natural Sciences and Engineering Research Council of Canada (NSERC) for our study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. END ...

LAST 30 PRESS RELEASES:

Novel discovery reveals how brain protein OTULIN controls tau expression and could transform Alzheimer's treatment

How social risk and “happiness inequality” shape well-being across nations

Uncovering hidden losses in solar cells: A new analysis method reveals the nature of defects

Unveiling an anomalous electronic state opens a pathway to room-temperature superconductivity

Urban natives: Plants evolve to live in cities

Folklore sheds light on ancient Indian savannas

AI quake tools forecast aftershock risk in seconds, study shows

Prevalence of dysfunctional breathing in the Japanese community and the involvement of tobacco use status: The JASTIS study 2024

Genetic study links impulsive decision making to a wide range of health and psychiatric risks

Clinical trial using focused ultrasound with chemotherapy finds potential survival benefit for brain cancer patients

World-first platform for transparent, fair and equitable use of AI in healthcare

New guideline standardizes outpatient care for adults recovering from traumatic brain injury

Physician shortage in rural areas of the US worsened since 2017

Clinicians’ lack of adoption knowledge interferes with adoptees’ patient-clinician relationship

Tip sheet and summaries Annals of Family Medicine November/December 2025

General practitioners say trust in patients deepens over time

Older adults who see the same primary care physician have fewer preventable hospitalizations

Young European family doctors show moderate readiness for artificial intelligence but knowledge gaps limit AI use

New report presents recommendations to strengthen primary care for Latino patients with chronic conditions

Study finds nationwide decline in rural family physicians

New public dataset maps Medicare home health use

Innovative strategy trains bilingual clinic staff as dual-role medical interpreters to bridge language gaps in primary care

Higher glycemic index linked to higher lung cancer risk

Metabolism, not just weight, improved when older adults reduced ultra-processed food intake

New study identifies key mechanism driving HIV-associated immune suppression 

Connections with nature in protected areas

Rodriguez and Phadatare selected for SME's 30 Under 30

Nontraditional benefits play key role in retaining the under-35 government health worker

UC Irvine-led study finds global embrace of integrative cancer care

From shiloh shepherds to chihuahuas, study finds that the majority of modern dogs have detectable wolf ancestry

[Press-News.org] Natural ‘biopesticide’ against malaria mosquitoes successful in early field tests
Powder made from dead bacterial cells also kills mosquitoes resistant to chemical pesticides